These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23892833)

  • 1. Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseases.
    Avdagić N; Babić N; Šeremet M; Delić-Šarac M; Drače Z; Denjalić A; Nakaš-Ićindić E
    Med Glas (Zenica); 2013 Aug; 10(2):211-6. PubMed ID: 23892833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
    Kucharzik T; Stoll R; Lügering N; Domschke W
    Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
    Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
    Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Could the cytokines concentration be a marker of IBD activity and be useful in evaluation of IBD differentiation?].
    Cieċko-Michalska I; Wierzbicka-Tutka I; Szczepanek M; Fedak D; Mach T
    Przegl Lek; 2016; 73(5):301-4. PubMed ID: 29629745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
    Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
    Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
    Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
    Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR.
    Komatsu M; Kobayashi D; Saito K; Furuya D; Yagihashi A; Araake H; Tsuji N; Sakamaki S; Niitsu Y; Watanabe N
    Clin Chem; 2001; 47(7):1297-301. PubMed ID: 11427462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2: a new and promising activity marker in ulcerative colitis.
    Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
    World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
    Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
    IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients.
    Spoettl T; Hausmann M; Klebl F; Dirmeier A; Klump B; Hoffmann J; Herfarth H; Timmer A; Rogler G
    Inflamm Bowel Dis; 2007 Jun; 13(6):727-32. PubMed ID: 17260368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tumor necrosis factor activity in inflammatory bowel disease.
    Maeda M; Watanabe N; Neda H; Yamauchi N; Okamoto T; Sasaki H; Tsuji Y; Akiyama S; Tsuji N; Niitsu Y
    Immunopharmacol Immunotoxicol; 1992; 14(3):451-61. PubMed ID: 1517530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
    Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
    World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.
    Vatay A; Bene L; Kovács A; Prohászka Z; Szalai C; Romics L; Fekete B; Karádi I; Füst G
    Immunogenetics; 2003 Jul; 55(4):247-52. PubMed ID: 12811429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.